HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
T Loosli, S Hossmann, SM Ingle, H Okhai… - The Lancet …, 2023 - thelancet.com
Background The widespread use of the integrase strand transfer inhibitor (INSTI)
dolutegravir in first-line and second-line antiretroviral therapy (ART) might facilitate …
dolutegravir in first-line and second-line antiretroviral therapy (ART) might facilitate …
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam
To curb HIV infection rate in Tanzania, antiretroviral therapy (ART) has been scaled up since
2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line …
2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line …
HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis
F Ouyang, D Yuan, W Zhai, S Liu, Y Zhou, H Yang - Viruses, 2024 - mdpi.com
Background: There are an increasing number of articles focused on the prevalence and
clinical impact of pretreatment HIV drug resistance (PDR) detected by Sanger sequencing …
clinical impact of pretreatment HIV drug resistance (PDR) detected by Sanger sequencing …
A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings
C Henegar, E Letang, R Wang, C Hicks, D Fox… - Viruses, 2023 - mdpi.com
After a decade of dolutegravir (DTG) use in various antiretroviral therapy combinations and
in diverse populations globally, it is critical to identify HIV strains with reduced drug …
in diverse populations globally, it is critical to identify HIV strains with reduced drug …
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021
L Viñuela, A De Salazar, A Fuentes… - Journal of Medical …, 2023 - Wiley Online Library
To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and
nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and …
nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and …
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study
S Uno, H Gatanaga, T Hayashida… - Journal of …, 2023 - academic.oup.com
Background Integrase strand transfer inhibitors (INSTIs) are recommended as first-line ART
for people living with HIV (PLWH) in most guidelines. The INSTI-resistance-associated …
for people living with HIV (PLWH) in most guidelines. The INSTI-resistance-associated …
HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola
CS Sebastião, AB Abecasis, D Jandondo… - Scientific Reports, 2024 - nature.com
The surveillance of drug resistance in the HIV-1 naïve population remains critical to
optimizing the effectiveness of antiretroviral therapy (ART), mainly in the era of integrase …
optimizing the effectiveness of antiretroviral therapy (ART), mainly in the era of integrase …
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21
Background Transmitted drug resistance (TDR) is still a critical aspect for the management
of individuals living with HIV-1. Thus, its evaluation is crucial to optimize HIV care. Methods …
of individuals living with HIV-1. Thus, its evaluation is crucial to optimize HIV care. Methods …
[HTML][HTML] Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)
Background A rapid ART initiation approach can be beneficial in people with advanced HIV
disease, in consideration of their high morbidity and mortality. The aim of our study was to …
disease, in consideration of their high morbidity and mortality. The aim of our study was to …
Characterization of Human Immunodeficiency Virus-1 Transmission Clusters and Transmitted Drug-Resistant Mutations in Croatia from 2019 to 2022
Molecular epidemiology of HIV-1 infection is challenging due to the highly diverse HIV-
genome. We investigated the genetic diversity and prevalence of transmitted drug resistance …
genome. We investigated the genetic diversity and prevalence of transmitted drug resistance …